Recombinant human hyaluronidase PH20-mediated dermal spreading activity in mice is not altered by steroids, antihistamines, or salicylic acid
| Autor: | Jessica Cowell, Curtis B. Thompson, Marie A. Printz |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
biology
medicine.medical_treatment 030209 endocrinology & metabolism Adrenocorticotropic hormone Pharmacology Cetirizine Immunoglobulin G 03 medical and health sciences Steroid hormone chemistry.chemical_compound 0302 clinical medicine Recombinant Human Hyaluronidase chemistry Hyaluronidase 030220 oncology & carcinogenesis medicine biology.protein Pharmacology (medical) Salicylic acid Dexamethasone medicine.drug |
| Zdroj: | Drug Metabolism and Drug Interactions. 36:155-163 |
| ISSN: | 2191-0162 0792-5077 |
| DOI: | 10.1515/dmpt-2020-0120 |
| Popis: | Objectives Drug–drug interaction studies for hyaluronidase safety assessments have evaluated only animal-derived enzyme preparations. We therefore set out to evaluate whether high-dose administration of two antihistamines, a potent corticosteroid, steroid hormone, adrenocorticotropic hormone (ACTH), or salicylic acid would alter the dispersive activity of recombinant human hyaluronidase PH20 (rHuPH20). Methods NCr nu/nu mice were pretreated with diphenhydramine, cetirizine, dexamethasone, estrogen, ACTH, salicylic acid, and/or neutral-buffered saline (NBS). An hour following final pretreatment, dosed mice were anesthetized with ketamine/xylazine and placed in an imaging chamber. A 120 mg/mL immunoglobulin G (IgG) solution with 0.3 μg/mL IgGDL755 (labeled IgG) was injected intradermally, with/without 2,000 U/mL rHuPH20. Fluorescent images of labeled IgG dispersion were acquired ≤20 min post injection. Results Dispersion of high-concentration labeled IgG combined with rHuPH20 was greater at all time points vs. antibody alone. At 20 min post injection (last time point), the antibody dispersion area was significantly increased with rHuPH20 vs. without rHuPH20 (p≤0.005). The relative percent increase in antibody dispersion with rHuPH20 ranged from 22.8‒106.6% over the 20-min time course, compared with the corresponding non-rHuPH20 treated groups. The area of labeled IgG dispersion was statistically similar between rHuPH20 groups pretreated with an active compound and their paired NBS pretreated controls. Conclusions The addition of 2,000 U/mL rHuPH20 to a high-concentration antibody solution reproducibly incre-ased local antibody dispersion. Systemic pretreatment with diphenhydramine, cetirizine, dexamethasone, estrogen, ACTH, or salicylic acid did not affect the enzymatic spreading activity of rHuPH20, as measured by intradermal dispersion of labeled IgG in mice. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|